• Je něco špatně v tomto záznamu ?

Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes

ER. Verrier, SA. Yim, L. Heydmann, H. El Saghire, C. Bach, V. Turon-Lagot, L. Mailly, SC. Durand, J. Lucifora, D. Durantel, P. Pessaux, N. Manel, I. Hirsch, MB. Zeisel, N. Pochet, C. Schuster, TF. Baumert,

. 2018 ; 68 (5) : 1695-1709. [pub] 20180710

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012712

Chronic hepatitis B virus (HBV) infection is a major cause of chronic liver disease and cancer worldwide. The mechanisms of viral genome sensing and the evasion of innate immune responses by HBV infection are still poorly understood. Recently, the cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) was identified as a DNA sensor. In this study, we investigated the functional role of cGAS in sensing HBV infection and elucidate the mechanisms of viral evasion. We performed functional studies including loss-of-function and gain-of-function experiments combined with cGAS effector gene expression profiling in an infectious cell culture model, primary human hepatocytes, and HBV-infected human liver chimeric mice. Here, we show that cGAS is expressed in the human liver, primary human hepatocytes, and human liver chimeric mice. While naked relaxed-circular HBV DNA is sensed in a cGAS-dependent manner in hepatoma cell lines and primary human hepatocytes, host cell recognition of viral nucleic acids is abolished during HBV infection, suggesting escape from sensing, likely during packaging of the genome into the viral capsid. While the hepatocyte cGAS pathway is functionally active, as shown by reduction of viral covalently closed circular DNA levels in gain-of-function studies, HBV infection suppressed cGAS expression and function in cell culture models and humanized mice. Conclusion: HBV exploits multiple strategies to evade sensing and antiviral activity of cGAS and its effector pathways.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012712
003      
CZ-PrNML
005      
20190409152004.0
007      
ta
008      
190405s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/hep.30054 $2 doi
035    __
$a (PubMed)29679386
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Verrier, Eloi R $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
245    10
$a Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes / $c ER. Verrier, SA. Yim, L. Heydmann, H. El Saghire, C. Bach, V. Turon-Lagot, L. Mailly, SC. Durand, J. Lucifora, D. Durantel, P. Pessaux, N. Manel, I. Hirsch, MB. Zeisel, N. Pochet, C. Schuster, TF. Baumert,
520    9_
$a Chronic hepatitis B virus (HBV) infection is a major cause of chronic liver disease and cancer worldwide. The mechanisms of viral genome sensing and the evasion of innate immune responses by HBV infection are still poorly understood. Recently, the cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) was identified as a DNA sensor. In this study, we investigated the functional role of cGAS in sensing HBV infection and elucidate the mechanisms of viral evasion. We performed functional studies including loss-of-function and gain-of-function experiments combined with cGAS effector gene expression profiling in an infectious cell culture model, primary human hepatocytes, and HBV-infected human liver chimeric mice. Here, we show that cGAS is expressed in the human liver, primary human hepatocytes, and human liver chimeric mice. While naked relaxed-circular HBV DNA is sensed in a cGAS-dependent manner in hepatoma cell lines and primary human hepatocytes, host cell recognition of viral nucleic acids is abolished during HBV infection, suggesting escape from sensing, likely during packaging of the genome into the viral capsid. While the hepatocyte cGAS pathway is functionally active, as shown by reduction of viral covalently closed circular DNA levels in gain-of-function studies, HBV infection suppressed cGAS expression and function in cell culture models and humanized mice. Conclusion: HBV exploits multiple strategies to evade sensing and antiviral activity of cGAS and its effector pathways.
650    _2
$a zvířata $7 D000818
650    _2
$a western blotting $7 D015153
650    _2
$a buněčné kultury $7 D018929
650    _2
$a DNA virů $x imunologie $7 D004279
650    _2
$a stanovení celkové genové exprese $x metody $7 D020869
650    _2
$a hepatitida B $x imunologie $x patofyziologie $7 D006509
650    _2
$a virus hepatitidy B $x patogenita $7 D006515
650    _2
$a hepatocyty $x metabolismus $x virologie $7 D022781
650    _2
$a interakce hostitele a patogenu $7 D054884
650    _2
$a lidé $7 D006801
650    _2
$a imunitní únik $x imunologie $x fyziologie $7 D057131
650    _2
$a hybridizace in situ fluorescenční $x metody $7 D017404
650    _2
$a myši $7 D051379
650    _2
$a nukleotidy cyklické $x metabolismus $7 D009712
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Yim, Seung-Ae $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Heydmann, Laura $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a El Saghire, Houssein $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Bach, Charlotte $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Turon-Lagot, Vincent $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Mailly, Laurent $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Durand, Sarah C $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Lucifora, Julie $u Inserm, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard, Lyon, France.
700    1_
$a Durantel, David $u Inserm, U1052, Cancer Research Center of Lyon (CRCL), Université de Lyon (UCBL1), CNRS UMR_5286, Centre Léon Bérard, Lyon, France.
700    1_
$a Pessaux, Patrick $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France. Pôle Hépato-Digestif, Institut Hospitalo-Universitaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
700    1_
$a Manel, Nicolas $u Immunity and Cancer Department, Institut Curie, PSL Research University, Paris, France. Inserm, U932, Paris, France.
700    1_
$a Hirsch, Ivan $u Department of Genetics and Microbiology, Faculty of Science, Biocev, Charles University; Institute of Organic Chemistry and Biochemistry, CAS, IOCB & Gilead Research Center, Prague, Czech Republic.
700    1_
$a Zeisel, Mirjam B $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Pochet, Nathalie $u Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Cell Circuits Program, Broad Institute of MIT and Harvard, Cambridge, MA.
700    1_
$a Schuster, Catherine $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France.
700    1_
$a Baumert, Thomas F $u Université de Strasbourg, Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMRS_1110, Strasbourg, France. Pôle Hépato-Digestif, Institut Hospitalo-Universitaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
773    0_
$w MED00009806 $t Hepatology (Baltimore, Md.) $x 1527-3350 $g Roč. 68, č. 5 (2018), s. 1695-1709
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29679386 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190409152019 $b ABA008
999    __
$a ok $b bmc $g 1392022 $s 1051017
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 68 $c 5 $d 1695-1709 $e 20180710 $i 1527-3350 $m Hepatology $n Hepatology $x MED00009806
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...